O2 RegenTech
Akron
About O2 RegenTech
O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions. Our proprietary, patented technology is used in our initial product offering, OXAID™, as an oxygenating, moist, and antimicrobial dressing to promote and accelerate chronic wound healing. Now live with a RegCF fundraising campaign: https://www.netcapital.com/companies/o2regentech
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $960.0K
- Funding stage: Seed
- Last round: Seed (Jul 2021)
- Website: o2regentech.com
- Phone: [email protected]
Industries & Categories
Clinical Trials, Commercial, Medical
Social Profiles
Canonical: https://fsome.com/organization/o2-regentech-136679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.